CJC-1295 (No DAC), Ipamorelin, GHRP-2 (Blend)

$80.00

CJC-1295 No DAC plus Ipamorelin plus GHRP-2 Blend is a three-active lyophilised vial combining the 30-residue GHRH analogue CJC-1295 with two ghrelin-receptor agonists: the selective pentapeptide Ipamorelin and the 6-amino-acid GHRP-2. For comparative ghrelin-class research. Each active >99 percent HPLC.

Category:

Peptide Science research editorial team.

CJC-1295 No DAC plus Ipamorelin plus GHRP-2 Blend Overview

CJC-1295 No DAC plus Ipamorelin plus GHRP-2 Blend from Peptide Science is a three-active lyophilised vial combining the 30-residue modified GHRH analogue CJC-1295 with two distinct ghrelin-receptor agonists: the selective pentapeptide Ipamorelin and the 6-amino-acid GHRP-2. The triple-active format supports preclinical research that compares ghrelin-receptor activation profiles in one experimental arm.

Combined GH-Axis Mechanism

CJC-1295 raises cAMP via the GHRH receptor. Ipamorelin is characterised in preclinical models for selective GH release with reported low cortisol and prolactin response, while GHRP-2 is the more broadly potent ghrelin agonist with stronger secondary endocrine activity. The combination allows direct in-vitro comparison of the two ghrelin-class profiles under the same baseline GHRH stimulation. Browse related compounds in the growth-hormone peptide range.

Vial Specifications

CJC-1295 No DAC plus Ipamorelin plus GHRP-2 Blend research specifications
Property Value
Active 1 CJC-1295 (No DAC) + GHRP-2, 30 / 6-amino-acid GHRH analogue plus ghrelin agonist
Active 2 Ipamorelin, 5-amino-acid selective pentapeptide ghrelin agonist
Combined strength 10 mg total per vial
Supplied form Lyophilised powder, sealed vial
Purity each active greater than 99 percent (HPLC verified)
Storage 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term

Reconstitution and Handling

The three-active vial reconstitutes with bacteriostatic water. For the simpler two-active variant pairing CJC-1295 with Ipamorelin alone, see CJC-1295 No DAC plus Ipamorelin 10mg Blend. For research using the more potent Hexarelin instead of GHRP-2 or Ipamorelin, see CJC-1295 No DAC plus Hexarelin 10mg Blend.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent for each active, with mass-spectrometry identity confirmation. A Certificate of Analysis listing each active and its measured purity accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging via overnight or two-day courier.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws. Lyophilised vials store at 2 to 8 degrees Celsius; protect from light.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 (No DAC), Ipamorelin, GHRP-2 (Blend)”

Your email address will not be published. Required fields are marked *

Scroll to Top